Crowberry, Empetrum nigrum var. japonicum, is widely used in folk medicine and grows naturally in Korea. Although some constituents and biological activity of Korean crowberry have been examined, there is little detailed information available. In this study, we investigated the effects of ethanol extracts of crowberry (EECB) on the inhibition of angiogenesis, both in vitro and in vivo. The effects of EECB were tested on in vitro models of angiogenesis, that is, tube formation and proliferation of human umbilical vein endothelial cells (HUVECs). EECB exhibited significant inhibitory effects on tube formation of HUVECs in a concentration-dependent manner. In addition, crowberry significantly suppressed the proliferation of HUVECs in a concentration-dependent manner. Furthermore, strong antiangiogenic activity of EECB samples was observed in the in vivo assay using chick embryo chorioallantoic membrane (CAM). These results indicate that crowberry may have potential applications in the prevention and treatment of angiogenesis-dependent human diseases.
Angiogenesis is defined as a process in which a network of new blood vessels emerges from preexisting vessels and, as such, is essential for tumor growth and metastasis. In the early 1970s, Judah Folkman first found that new blood vessel growth was required for a tumor to grow over a few mm 3 in size, supplying the tumor with nutrition and oxygen for its exponential growth [1] . Endothelial cells play a key role in the formation of such neovessels [2] . Antiangiogenic treatment may be useful in the treatment and prevention of cancer progression. If found, food factors capable of inhibiting angiogenesis would be useful to stop the progression of small cancers [3] .
Crowberry is one of the most common wild berries in the northern hemisphere such as in Canada, Eurasia, Greenland, and northern Europe [4] . One species of crowberry, Empetrum nigrum L. var. japonicum, grows naturally in Korea. The Korean crowberry (named Shiromi) is widely used in folk medicine and is a narrow endemic species found at altitudes above 1,400 meters on Mt. Halla on Jeju Island. It has been reported that crowberry contains a wide range of phenolic compounds and a very high amount of anthocyanins [5] [6] [7] . In our previous report, we reported the ethanol extracts of crowberry had higher total polyphenol and anthocyanin contents than those from blueberry and mulberry [7] . Furthermore, the major anthocyanins of crowberry were cyanidin-3-galactoside and delphinidin-3-galactoside. Park et al. also found that the leaf and fruit extracts of crowberry exhibited strong effects on the inhibition of low density lipoprotein oxidation [8] . Kim et al. reported that crowberry protects cells against γ-radiation-induced oxidative stress via the reduction of ROS and attenuation of apoptosis [9] . In addition, crowberry extract restores the cellular antioxidant enzyme activities of superoxide dismutase, catalase, glutathione peroxidase, and heme oxygenase-1, which were reduced by H 2 O 2 treatment [10] . However, there have been only a limited number of reports concerning the biological effects of crowberry and no studies of the effects of crowberry on angiogenesis.
Therefore, in this study, we investigated the in vitro and in vivo antiangiogenic activities of the ethanol extracts of crowberry (EECB). We analyzed the effects of EECB on angiogenesis in vitro through inhibition of tube formation and endothelial cell proliferation. Furthermore, we used the chick embryo chorioallantoic membrane (CAM) assay system to evaluate the in vivo angiogenic activity of EECB. To our knowledge, this is the first report that describes the antiangiogenic activity of crowberry using in vitro and in vivo models.
Inhibition of HUVEC tube formation by crowberry:
We first examined the effect of crowberry on angiogenesis in vitro using a tube formation model of HUVECs cultured in a two-dimensional system. After induction of tube formation, the endothelial cells formed a network of capillary-like tubes that were composed of multiple cells that gathered together and adhered to each other. Figure 1 shows the inhibitory effects of EECB on tube formation of endothelial cells. At concentrations of 31.3 and 62.5 µg/mL, EECB slightly reduced the width of the tubes. At concentrations of 125 and 250 µg/mL, EECB reduced both the width and the length of the tubes. At a concentration of 500 µg/mL, EECB completely inhibited elongation of HUVECs in a concentration-dependent manner. Area ratios of the tubes per pictured field were 30.8, 26.5, 24.5, 19.8, 17.8, and 10.2% at concentrations of 0, 31.3, 62.5, 125, 250, and 500 µg/mL, respectively, which were calculated to be 86.2%, 79.6%, 64.4%, 57.8%, and 33.2% (% of control) at concentrations of 31.3, 62.5, 125, 250, and 500 µg/mL, respectively ( Figure 1g ).
Inhibition of HUVEC proliferation by crowberry:
We then examined the effects of crowberry on endothelial cell proliferation, another in vitro model of angiogenesis ( Figure 2 ). EECB significantly reduced cell proliferation to 96.0%, 80.5%, and 39.8% at concentrations of 31.3, 125, and 500 µg/mL, respectively, compared with the control. Thus, crowberry inhibited cell proliferation in a concentration-dependent manner, with a projected IC 50 of 425.5 µg/mL. These results demonstrated that EECB has antiangiogenic activity via the inhibition of endothelial cell proliferation.
Suppression of chorioallantoic membrane (CAM) angiogenesis in vivo by crowberry:
In vivo angiogenic activity of crowberry was assayed using the chick CAM assay. Retinoic acid (5 nmol/egg), which is known to have antiangiogenic activity, was used as a positive control [11] . EECB samples (25-200 µg/egg) significantly inhibited new blood vessel growth of chick embryos and suppressed embryonic angiogenesis in a dose-dependent manner (Figure 3) . At a concentration of 200 µg/egg, EECB samples showed similar antiangiogenic effects compared with retinoic acid. Antiangiogenesis rates were 69.6% for retinoic acid and 35.8%, 50.8%, 60.0%, and 67.3% for EECB (25, 50, 100, and 200 µg/egg), respectively, compared with the negative control.
Phenolic compounds are commonly found in both edible and nonedible plants, and they have been reported to have various biological activities [12] . Berries contain a wide variety of phenolic compounds such as phenolic acids, flavonoids, and anthocyanins. It has been suggested that flavonoids and other phenolic substances play a preventive role in the development of cancer and heart disease [12, 13] . Takikawa et al. reported that dietary consumption of bilberry polyphenolics significantly reduced blood glucose level and enhanced insulin sensitivity via activation of AMP-activated protein kinase in vivo [14] . Zafra-Stone et al. demonstrated that the berry anthocyanins not only had strong antiatherosclerotic activity but also had strong antioxidant activity [15] . We also reported the anthocyanin composition and antioxidant activity of five berry species [7] . It has been shown that the major anthocyanins of crowberry were cyanidin-3-galactoside and delphinidin-3-galactoside. Crowberry, especially, had relatively strong antioxidant activity, which was consistent with the high total polyphenol and anthocyanin contents in comparison with the other berry samples.
Antiangiogenic activity of crowberry (Empetrum nigrum var. japonicum)
Natural Product Communications Vol. 11 (4) 2016 505 In this study, we found for the first time that crowberry possesses antiangiogenic activity both in vitro and in vivo. Although some researchers have reported that crowberry possesses various biological activities, there are no reports on its antiangiogenic effects. Therefore, these results strongly suggest that regular consumption of crowberry may be beneficial in reducing the risk of developing angiogenesis-related diseases. We are studying further the mechanism of inhibition of angiogenesis by crowberry at cellular and molecular levels.
Experimental
Materials: MCDB-104 medium was purchased from Nihon Pharmaceutical (Tokyo, Japan), fetal bovine serum (FBS) from Moregate (Brisbane, Australia), atelocollagen bovine dermis (type I collagen) from Koken (Tokyo, Japan), epidermal growth factor (EGF) from BD Biosciences (Bedford, MA), and human basic fibroblast growth factor (bFGF) (Recombinant) from Austral Biologicals (San Ramon, CA, USA). Unless otherwise stated, all chemicals were purchased from Sigma (St. Louis, MO, USA). Fertilized chicken eggs were obtained from Pulmuone Farm (Danyang, Korea). Fat emulsion (20%) was from Green Cross Pharmacy Co. (Seoul, Korea).
Sample preparation: Crowberry (Empetrum nigrum var. japonicum) was collected at Mt. Halla at an altitude above 1,400 meters in August 2013. The extraction method was adapted from that of Park et al., with some modifications [8] . In brief, the crowberry was lyophilized using a freeze-dryer Eyela-5N (Tokyo Rikakikai. Co., Ltd., Tokyo, Japan) and was extracted with 80% ethanol at room temperature for 72 h. The ethanol suspensions were separated by centrifugation at 4,000 rpm for 10 min at 4°C, and the supernatants were concentrated under reduced pressure to give ethanol extracts of crowberry (EECB). EECB was stored under dry conditions at 4°C until analyzed.
Tube formation assay: HUVECs were grown in HUVEC growth medium (MCDB-104 medium supplemented with 10 ng/mL EGF, 100 µg/mL heparin, 100 ng/mL endothelial cell growth factor, and 10% FBS), as previously reported [16] . HUVECs were induced to form capillary tube-like structures in type I collagen gel (Cellgen) as previously described, with slight modifications [16] . Briefly, HUVECs (6.0 × 10 4 cells/cm 2 ) were seeded between 2 layers of collagen gel (0.21% collagen) and incubated in MCDB-104 supplemented with 0.5% FBS, 10 ng/mL bFGF, 8 nM/mL phorbol 12-myristate 13-acetate, and 25 µg/mL ascorbic acid. They were treated with various concentrations of EECB (31.3, 62.5, 125, 250, and 500 µg/mL) for up to 24 h. The tube morphology was photographed at the indicated time. The tube formation was quantified by determining the pixel number of the tubes in each image using the NIH Image program.
Measurement of proliferation inhibition of cells:
HUVECs were seeded onto gelatin-coated 24-multiwell plates at a density of 1.0 × 10 4 cells/cm 2 in HUVEC growth media. After 24 h incubation at 37°C in a 5% CO 2 incubator, EECB was added to the wells (31.3, 125, and 500 µg/mL) and the cells were further cultured for 3 days. The number of cells was counted with a Coulter Counter (Coulter Electronics, Hialeah, USA).
CAM assay:
The CAM assay was performed as described previously, with slight modifications [11, 17] . Briefly, fertilized chicken eggs were kept in a humidified incubator at 37°C. After 5 days of incubation, approximately 4 mL of albumin was aspirated from the eggs with an 18 gauge hypodermic needle through a small hole drilled at the narrow end of the eggs, allowing the small CAM and yolk sac to drop away from the shell membrane. Onto 6-day-old fertilized chicken embryos in the shells, 10 µL aliquots of either EECB (25, 50, 100, and 200 µg/egg) or retinoic acid (5 nmol/egg), as a positive control mixed in 1% methylcellulose, were applied into 2 mm silicon rings placed on the surface of the growing CAM. After 2 days incubation, an appropriate volume of a 20% fat emulsion was injected into the CAM to visualize the blood vessels. At least 15 eggs were used for each condition, and experiments were repeated 6 times. The results were expressed as a suppression ratio of new vessels within the area encircled by a white ring.
Statistical analysis:
Results were presented as mean ± SE obtained from either 3 or 6 independent experiments. Data were evaluated statistically using one-way analysis of variance (ANOVA) followed by Holm-Sidak method and using Student t-test for analysis between control and treatments. Statistical significance was preset at *P < 0.05.
